Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de la Réunion

Transfusion

Volumn 49, Issue 6, 2009, Pages 1083-1091

  Corash, Laurence ^a   Rasonglès, Patrice ^b   Angelini Tibert, Marie France ^b   Simon, Philip ^b   Currie, Caroline ^b   Isola, Herve ^b   Kientz, Daniel ^b   Slaedts, Marc ^b   Jacquet, Michele ^b   Sundin, David ^b   Lin, Lily ^b   Cazenave, Jean Pierre ^b  

^a CERUS CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LUNG INJURY; ADULT; ANXIETY DISORDER; ARTICLE; BLOOD TRANSFUSION REACTION; CHIKUNGUNYA ALPHAVIRUS; CHILD; CHILL; CLINICAL PRACTICE; CONTROLLED STUDY; FEMALE; FEVER; FRANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; SEPSIS; THROMBOCYTE TRANSFUSION; URTICARIA; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHAVIRUS INFECTIONS; BLOOD DONORS; CHIKUNGUNYA VIRUS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PHOTOCHEMISTRY; PLATELET TRANSFUSION; PSORALENS; RETROSPECTIVE STUDIES; ULTRAVIOLET RAYS;

EID: 66549083222     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02111.x     Document Type: Article

References (26)

1. Brouard C, Bernillon P, Quatresous I, Pillonel J, Assal A, De Valk H, Desenclos JC workgroup "Quantitative Estimation of the Risk of Blood Donation Contamination by Infectious Agents Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008 48 : 1333 41.
2. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Bréhin AC, Cubito N, Desprès P, Kunst F, Rey FA, Zeller H, Brisse S. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 2006 3 : 1 16.
3. Krastinova E, Quatresous I, Tarantola A. Imported cases of Chikungunya in metropolitan France: update to June 2006. Euro Surveill 2006 11 : E060821 060824.
4. Cordel H, Quatresous I, Paquet C, Couturier E. Imported cases of Chikungunya in metropolitan France, April 2005-February 2006. Euro Surveill 2006 11 : E060420 060423.
5. Rasongles P, Isola H, Kientz D, Cazenave JP, Sawyer L, Corash L. Rapid implementation of photochemical pathogen inactivation (INTERCEPT) for preparation of platelet components during an epidemic of Chikungunya virus. Vox Sang 2006 91 (Suppl 3 32.
6. Sawyer L, Sampson-Johannes A, Dubensky T, Kinsey J, Tsetsarkin K, Vanlandingham DL, Higgs S. Inactivation of chikungunya virus in platelets and plasma using the INTERCEPT Blood System™. Vox Sang 2007 93 (Suppl 1 170.
7. Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L. Photochemical treatment of platelet concentrates with amotosalen and UVA inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 504.
8. Lin L, Hanson CV, Alter HJ, Jauvin V, Bernard KA, Murthy KK, Metzel P, Corash L. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light. Transfusion 2005 45 : 580 90.
9. Castro E, Girones N, Bueno JL, Carrion J, Lin L, Fresno M. The efficacy of photochemical treatment with amotosalen HCl and ultraviolet A (INTERCEPT) for inactivation of Trypanosoma cruzi in pooled buffy-coat platelets. Transfusion 2007 47 : 434 41.
10. Angelini MF, Fressy P, Rasongles P. Epidémie de chikungunya à la Réunion et transfusion sanguine. Le Bulletin de l' Hemovigilance de l'Afssaps 2006 13 : 9 10.
11. Andreu G, Morel P, Forestier F, Rebibo D, Janvier G, Herve P. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994-1998. Transfusion 2002 42 : 1356 64.
12. Osselaer JC, Messe N, Hervig T, Bueno J, Castro E, Espinosa A, Accorsi P, Junge K, Jacquet M, Flament J, Corash L. A prospective observational cohort safety study of 5106 platelet transfusions using components prepared with photochemical pathogen inactivation treatment. Transfusion 2008 48 : 1061 71.
13. Bernard GR, Artigas A, Brigham KL. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994 149 : 818 42.
14. Osselaer JC, Cazenave JP, Lambermont M, Garraud O, Hidajat M, Barbolla L, Tardivel R, Defoin L, Waller C, Mendel I, Raidot JP, Kandel G, De Meuter R, Fabrigli P, Dehenau D, Arroyo JL, Padrón F, Gouezec H, Corral M, Jacquet M, Sundin D, Lin L, Corash L. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment. Vox Sang 2008 94 : 315 23.
15. Mantke OD, Niedrig M, ENIVD. Laboratory capacity for detection of chikungunya virus infections in Europe. Euro Surveill 2007 12. Available from: http://www.eurosurveillance.org/ew/2007/070913.asp#2
16. Laurent P, Le Roux K, Grivard P, Bertil G, Naze F, Picard M, Staikowsky F, Barau G, Schuffenecker I, Michault A. Development of a sensitive real-time reverse transcriptase PCR assay with an internal control to detect and quantify chikungunya virus. Clin Chem 2007 53 : 1408 14.
17. Chernesky MA, Larke RP. Contrasting effects of rabbit and human platelets on chikungunya virus infectivity. Can J Microbiol 1977 23 : 1237 44.
18. Larke RP, Wheelock EF. Stabilization of chikungunya virus infectivity by human blood platelets. J Infect Dis 1970 122 : 523 31.
19. Angelini-Tibert MF, Rasongles P. Intolerance des CPA traites par INTERCEPT - Amotosalen en onco-pediatrie. Paris : Etablissement Francais du Sang 2007.
20. van Rhenen D J, Gulliksson H, Cazenave JP, Pamphilon D, Ljungman P, Klüter H, Vermeij H, Kappers-Klunne M, de Greef G, Laforet M, Lioure B, Davis K, Marblie S, Mayaudon V, Flament J, Conlan M, Lin L, Metzel P, Buchholz D, Corash L euroSPRITE trial. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003 101 : 2426 33.
21. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th., Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood 2004 104 : 1534 41.
22. Renault P, Solet JL, Sissoko D. A major epidemic of chikungunya virus infection on Reunion Island, France, 2005-2006. Am J Trop Med Hyg 2007 77 : 727 31.
23. Angelini-Tibert MF, Currie C, Slaedts M, Corash LM, Rasongles P. Safety of platelet components prepared with photochemical treatment (INTERCEPT) transfused to pediatric oncology-hematology patients. Transfusion 2007 43 : 22A.
24. Depoortere E, Coulombier D. Chikungunya risk assessment for Europe: recommendations for action. Euro Surveill 2006 11. Available from: http://www.eurosurveillance.org/ew/2006/060511.asp#2
25. Warner E, Garcia-Diaz J, Balsamo G, Shranatan S, Bergmann A, Blauwet L, Sohail M, Baddour L, Reed C, Baggett H, Campbell G, Smith T, Powers A, Hayes N, Noga A, Lehman J. Chikungunya fever diagnosed among international travelers - United States, 2005-2006. MMWR Morb Mortal Wkly Rep 2006 55 : 1040 2.
26. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A CHIKV study group. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007 370 : 1840 6.